![](/img/cover-not-exists.png)
Preclinical safety of a nucleic acid-targeted helinx TM compound: A clinical perspective
Vic CiaravinoVolume:
38
Year:
2001
Language:
english
DOI:
10.1016/s0037-1963(01)90119-2
File:
PDF, 1.16 MB
english, 2001